Sex differences have been widely reported in neuroinflammatory disorders, focusing on the contributory role of estrogen. The microvascular endothelium of the brain is a critical component of the blood-brain barrier (BBB) and it is recognized as a major interface for communication between the periphery and the brain. As such, the cerebral capillary endothelium represents an important target for the peripheral estrogen neuroprotective functions, leading us to hypothesize that estrogen can limit BBB breakdown following the onset of peripheral inflammation.
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Comparison of male and female murine responses to peripheral LPS challenge revealed a short-term inflammation-induced deficit in BBB integrity in males that was not apparent in young females, but was notable in older, reproductively senescent females. Importantly, ovariectomy and hence estrogen loss recapitulated an aged phenotype in young females, which was reversible upon estradiol replacement. Using a well-established model of human cerebrovascular endothelial cells we investigated the effects of estradiol upon key barrier features, namely paracellular permeability, transendothelial electrical resistance, tight junction integrity and lymphocyte transmigration under basal and inflammatory conditions, modeled by treatment with TNFa and IFNc. In all cases estradiol prevented inflammation-induced defects in barrier function, action mediated in large part through up-regulation of the central coordinator of tight junction integrity, annexin A1. The key role of this protein was then further confirmed in studies of human or murine annexin A1 genetic ablation models.
Together, our data provide novel mechanisms for the protective effects of estrogen, and enhance our understanding of the beneficial role it plays in neurovascular/neuroimmune disease.
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Introduction
Several lines of evidence suggest that the sex differences seen in vascular and neural diseases may be at least partly linked to differing sex hormone complements. In particular, a number of beneficial effects have been attributed to the principal female hormone estrogen, including in conditions as diverse as Parkinson's disease, Alzheimer's disease, head injury and multiple sclerosis (Gillies and McArthur, 2010) . One important working hypothesis is that the neuroprotective effects of estrogen may be related to its known anti-inflammatory and immunomodulatory actions (Czlonkowska et al., 2005; Nadkarni and McArthur, 2013) .
The endothelium of the blood-brain barrier (BBB) is at the forefront of the defensive features of the central nervous system, regulating its interactions with the immune system. In particular, there is accumulating evidence that BBB function is compromised during peripheral inflammation, leading to inappropriate passage of cells and molecules into the brain parenchyma (Carvey et al., 2009) . Estrogen has been shown to exert a variety of antiinflammatory effects, including reducing iNOS activity (Cignarella et al., 2009) , directly regulating the cytokine milieu (Gameiro et al., 2010) and altering expression of vascular and leukocyte adhesion molecules (Dietrich, 2004 
